Point72 (Difc) LTD Nuvation Bio Inc. Transaction History

Point72 (Difc) LTD

$2.95 Trillion
Q3 2024

A detailed history of Point72 (Difc) LTD transactions in Nuvation Bio Inc. stock. As of the latest transaction made, Point72 (Difc) LTD holds 9,495 shares of NUVB stock, worth $27,440. This represents 0.0% of its overall portfolio holdings.

Number of Shares

9,495

Holding current value

$27,440

% of portfolio

0.0%

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2024 Nov 14, 2024	BUY	$2.3 - $3.83 $21,838 - $36,365	9,495 New	9,495 $21.7 Million
Q1 2024 May 15, 2024	BUY	$1.46 - $3.97 $22,289 - $60,609	15,267 New	15,267 $55.6 Million

Others Institutions Holding NUVB

# of Institutions

159

Shares Held

157M

Call Options Held

3.2K

Put Options Held

98.7K

Decheng Capital LLC Menlo Park, CA

26M
Shares

$75 Million
14.08% of portfolio
Eco R1 Capital, LLC San Francisco, CA

19.2M
Shares

$55.5 Million
1.92% of portfolio
Black Rock Inc. New York, NY

16.2M
Shares

$46.9 Million
0.0% of portfolio
Omega Fund Management, LLC Boston, MA

13.1M
Shares

$37.8 Million
44.61% of portfolio
Octagon Capital Advisors LP New York, NY

12.2M
Shares

$35.2 Million
6.76% of portfolio

View Full List

About Nuvation Bio Inc.

Ticker NUVB
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 217,244,000
Market Cap $628M
Description
Nuvation Bio Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutic candidates for oncology. The company's lead product candidate is NUV-422, a small molecule inhibitor targeting cyclin-dependent kinase (CDK)2, CDK4, and CDK6. It is also developing NUV-868, a selective oral small molecule BET inhibitor that e...

More about NUVB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 (Difc) LTD, based on Form 13F filings with the SEC.

News

Stay updated on Point72 (Difc) LTD with notifications on news.

Account